Lingling Wei - Search Results

Year	Number of Results
2002	1
2003	1
2007	1
2008	3
2009	2
2010	3
2011	3
2012	6
2013	5
2014	5
2015	3
2016	2
2017	3
2018	9
2019	16
2020	12
2021	15
2022	13
2023	12
2024	13

1

Editorial: Immune-mediated damage to the heart and lungs in autoimmune diseases.

Wei L, Hydbring P, Long L. Wei L, et al. Front Immunol. 2024 Apr 5;15:1407748. doi: 10.3389/fimmu.2024.1407748. eCollection 2024. Front Immunol. 2024. PMID: 38646522 Free PMC article. No abstract available.

2

Editorial: Cell Transplantation in Diabetes: Cell-Based Immunotherapy for Type 1 Diabetes.

Wei L, Yamada K, Wang P. Wei L, et al. Front Endocrinol (Lausanne). 2022 May 2;13:887858. doi: 10.3389/fendo.2022.887858. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35586629 Free PMC article. No abstract available.

3

Research Advances in Genetic Mechanisms of Major Cucumber Diseases Resistance.

He Y, Wei M, Yan Y, Yu C, Cheng S, Sun Y, Zhu X, Wei L, Wang H, Miao L. He Y, et al. Among authors: wei l. Front Plant Sci. 2022 May 19;13:862486. doi: 10.3389/fpls.2022.862486. eCollection 2022. Front Plant Sci. 2022. PMID: 35665153 Free PMC article. Review.

4

Catalytic Chiral Photochemistry Sensitized by Chiral Hosts-Grafted Upconverted Nanoparticles.

Rao M, Fan C, Ji J, Liang W, Wei L, Zhang D, Yan Z, Wu W, Yang C. Rao M, et al. Among authors: wei l. ACS Appl Mater Interfaces. 2022 May 11;14(18):21453-21460. doi: 10.1021/acsami.2c02313. Epub 2022 Apr 29. ACS Appl Mater Interfaces. 2022. PMID: 35486103

5

ANGPTL3 is a novel HDL component that regulates HDL function.

Yang L, Wang Y, Xu Y, Li K, Yin R, Zhang L, Wang D, Wei L, Lang J, Cheng Y, Wang L, Ke J, Zhao D. Yang L, et al. Among authors: wei l. J Transl Med. 2024 Mar 10;22(1):263. doi: 10.1186/s12967-024-05032-x. J Transl Med. 2024. PMID: 38462608 Free PMC article.

6

Isolation and Purification of Human Pancreatic Islets.

Wei L. Wei L. Methods Mol Biol. 2023;2592:219-232. doi: 10.1007/978-1-0716-2807-2_16. Methods Mol Biol. 2023. PMID: 36507997

7

Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis.

Liu Y, Cheng Z, Zha B, Chen X, Gong Z, Ji L, Wei L. Liu Y, et al. Among authors: wei l. Lupus. 2023 Oct;32(11):1310-1319. doi: 10.1177/09612033231202398. Epub 2023 Sep 12. Lupus. 2023. PMID: 37699157

8

Characterisation and functional analysis of canine TLR5.

Zhu A, Wei L, Hu S, Yang C, Chen C, Zhou Z, Pan Z. Zhu A, et al. Among authors: wei l. Innate Immun. 2020 Aug;26(6):451-458. doi: 10.1177/1753425920901862. Epub 2020 Jan 27. Innate Immun. 2020. PMID: 31986950 Free PMC article.

9

Diabetogenic agent alloxan is a proteasome inhibitor.

Zhou W, Wei L, Xiao T, Lai C, Peng M, Xu L, Luo X, Deng S, Zhang F. Zhou W, et al. Among authors: wei l. Biochem Biophys Res Commun. 2017 Jun 24;488(2):400-406. doi: 10.1016/j.bbrc.2017.05.065. Epub 2017 May 11. Biochem Biophys Res Commun. 2017. PMID: 28502636

10

Cyclodextrin-based metal-organic frameworks transforming drug delivery.

Yang N, Wei L, Teng Y, Yu P, Xiang C, Liu J. Yang N, et al. Among authors: wei l. Eur J Med Chem. 2024 May 29;274:116546. doi: 10.1016/j.ejmech.2024.116546. Online ahead of print. Eur J Med Chem. 2024. PMID: 38823266 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

116 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year